Joel W. Reid - Canadian Light Source Inc. (CLS)

基本信息

Career Trajectory

Bio

I help industrial and academic clients answer questions with synchrotron techniques, primarily powder diffraction (PXRD) and X-ray absorption spectroscopy (XAS).

Research Interests

Papers共 121 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Combined 7li NMR, Density Functional Theory and Operando Synchrotron X-ray Powder Diffraction to Investigate a Structural Evolution of Cathode Material LiFeV2O7

Taiana L. E. Pereira,Jon Serrano Sevillano,Beatriz D. Moreno,Joel W. Reid,Dany Carlier,Gillian R. Goward

FARADAY DISCUSSIONS (2024)

Cited1Views0WOSBibtex

Potential for High-Grade Recovery of Rare Earth Elements and Cobalt from Acid Mine Drainage Via Adsorption to Precipitated Manganese (IV) Oxides

Charles T. Depp,Aaron J. Goodman,Peter.E.R. Blanchard, Scott E. Massimi,Joel W. Reid,Anthony J. Bednar,James F. Ranville

Chemospherepp.143144, (2024)

Cited0Views0WOSBibtex

Crystal Structure of Perfluorononanoic Acid, C9HF17O2

Joel W. Reid, Trimaan Malik,Michael G. Pravica,Adam F. G. Leontowich,Aly Rahemtulla

POWDER DIFFRACTION (2024)

Cited0Views0Bibtex

Palbociclib in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/refractory Acute Lymphoblastic Leukemia and Lymphoma: A Children's Oncology Group Study (AINV18P1)

Elizabeth A. Raetz,David T. Teachey,Charles Minard,Xiaowei Liu,Robin E. Norris,Kristina Z. Denic,Joel Reid,Nikki A. Evensen,Lia Gore,Elizabeth Fox,Mignon L. Loh,Brenda J. Weigel,William L. Carroll

PEDIATRIC BLOOD & CANCER（2024）

Cited8Views0WOSBibtex

Neoadjuvant (Z)-Endoxifen in Premenopausal ER+, HER2-breast Cancer: Evaluation of the First Pharmacokinetic Cohort of the EVANGELINE Trial

Matthew P. Goetz,Vera J. Suman, Heather Fraser,Lida Mina,Pooja Advani,Roberto Leon-Ferre,Karthik Giridhar,Felipe Batalini,Katie N. Hunt,Swaathi Jayaraman,James Jakub,Patricia Cronin,Mara Piltin,Amy Degnim,James N. Ingle,Judy C. Boughey,Sarah Buhrow,Joel Reid,Matthew Schellenberg,John Hawse, Steven Quay

CANCER RESEARCHno. 7 (2024)

Cited0Views0Bibtex

A Physiologically Based Pharmacokinetic Modeling Approach for Predicting the Exposure of Irinotecan and Its Active Metabolite (SN-38) in Cancer Patients

Kristina Zoran Denic,Sibylle Neuhoff,Joel Reid, Rachel Kudget

MOLECULAR CANCER THERAPEUTICSno. 12 (2023)

Cited0Views0Bibtex

Discordant in Vitro and in Vivo Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive Versus -Resistant Glioblastoma Multiforme Xenografts

Shiv K. Gupta,Ann C. Mladek,Brett L. Carlson,Felix Boakye-Agyeman,Katrina K. Bakken,Sani H. Kizilbash,Mark A. Schroeder,Joel Reid,Jann N. Sarkaria

crossref（2023）

Cited63Views0WOSBibtex

Abstract A140: A Physiologically Based Pharmacokinetic Modeling Approach for Predicting the Exposure of Irinotecan and Its Active Metabolite (SN-38) in Cancer Patients

Kristina Zoran Denic,Sibylle Neuhoff,Joel Reid, Rachel Kudget

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

Cited0Views0Bibtex

Endoxifen Downregulates AKT Phosphorylation Through Protein Kinase C Beta 1 in ER+/HER2-Breast Cancer

Swaathi Jayaraman,Xinyan Wu,Krishna R. Kalari,Xiaojia Tang,Mary Kuffel,Elizabeth S. Bruinsma,Santosh Renuse,James N. Ingle,Joel Reid,Matthew Schellenberg,John Hawse,Akhilesh Pandey,Matthew P. Goetz

CANCER RESEARCHno. 5 (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn